Hyman Charles D Eli Lilly & CO Transaction History

Hyman Charles D

$1.79 Billion
Q2 2024

A detailed history of Hyman Charles D transactions in Eli Lilly & CO stock. As of the latest transaction made, Hyman Charles D holds 15,143 shares of LLY stock, worth $11.9 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

15,143

Previous 15,268 0.82%

Holding current value

$11.9 Million

Previous $11.9 Million 15.43%

% of portfolio

0.76%

Previous 0.66%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$724.87 - $909.04 $90,608 - $113,630	-125 Reduced 0.82%	15,143 $13.7 Million
Q1 2024 May 07, 2024	SELL	$592.2 - $792.28 $79,947 - $106,957	-135 Reduced 0.88%	15,268 $11.9 Million
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $10,503 - $12,382	-20 Reduced 0.13%	15,403 $8.98 Million
Q3 2023 Nov 01, 2023	SELL	$434.7 - $599.3 $343,413 - $473,446	-790 Reduced 4.87%	15,423 $8.28 Million
Q2 2023 Aug 08, 2023	BUY	$350.74 - $468.98 $26,305 - $35,173	75 Added 0.46%	16,213 $7.6 Million
Q1 2023 May 04, 2023	BUY	$310.63 - $364.82 $15,531 - $18,241	50 Added 0.31%	16,138 $5.54 Million
Q4 2022 Feb 06, 2023	SELL	$321.55 - $374.67 $43,409 - $50,580	-135 Reduced 0.83%	16,088 $5.89 Million
Q3 2022 Nov 09, 2022	SELL	$296.48 - $337.87 $44,472 - $50,680	-150 Reduced 0.92%	16,223 $5.25 Million
Q2 2022 Aug 02, 2022	SELL	$278.73 - $327.27 $512,863 - $602,176	-1,840 Reduced 10.1%	16,373 $5.31 Million
Q1 2022 May 09, 2022	BUY	$234.69 - $291.66 $933,596 - $1.16 Million	3,978 Added 27.95%	18,213 $5.22 Million
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $652,065 - $809,216	2,900 Added 25.58%	14,235 $3.93 Million
Q2 2021 Aug 05, 2021	SELL	$180.55 - $233.54 $99,302 - $128,447	-550 Reduced 4.63%	11,335 $2.6 Million
Q1 2021 Apr 28, 2021	SELL	$164.32 - $212.72 $69,671 - $90,193	-424 Reduced 3.44%	11,885 $2.22 Million
Q4 2020 Feb 08, 2021	BUY	$130.46 - $172.63 $368,419 - $487,507	2,824 Added 29.77%	12,309 $2.08 Million
Q3 2020 Oct 26, 2020	SELL	$146.22 - $169.13 $51,177 - $59,195	-350 Reduced 3.56%	9,485 $1.4 Million
Q1 2020 Apr 30, 2020	SELL	$119.05 - $147.35 $31,548 - $39,047	-265 Reduced 2.62%	9,835 $1.36 Million
Q4 2019 Feb 03, 2020	BUY	$106.92 - $132.43 $56,133 - $69,525	525 Added 5.48%	10,100 $1.33 Million
Q2 2019 Jul 24, 2019	BUY	$110.79 - $129.32 $11,079 - $12,932	100 Added 1.06%	9,575 $1.06 Million
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $509,243 - $599,416	4,575 Added 93.37%	9,475 $1.23 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $34,344 - $42,924	-400 Reduced 7.55%	4,900 $526,000
Q2 2017 Aug 14, 2017	BUY	N/A	5,300	5,300 $436,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hyman Charles D, based on Form 13F filings with the SEC.

News

Stay updated on Hyman Charles D with notifications on news.

Account